Brief: Oncozenge Enters Into SEK 30.2 Mln Investment Agreement With Strategic Investor Sichuan Yangtian Bio-Pharmaceutical

Oncozenge AB

27/01/2025 18:02

Jan 27 (Reuters) - Oncozenge AB  ONCOZ.ST :
    * ONCOZENGE ENTERS INTO SEK 30.2 MILLION INVESTMENT
AGREEMENT WITH
NEW STRATEGIC INVESTOR SICHUAN YANGTIAN BIO-PHARMACEUTICAL,
INTENDED TO BE CARRIED OUT THROUGH DIRECTED SHARE ISSUES
    * ONCOZENGE AB - INVESTOR TO SUBSCRIBE FOR 4,669,647 NEW
SHARES AT
SEK 6.47 PER SHARE
    * ONCOZENGE AB - INVESTOR TO GAIN 28.5% OWNERSHIP STAKE IN
ONCOZENGE
    * ONCOZENGE AB - INVESTOR WILL GAIN A TOTAL OWNERSHIP STAKE
IN
COMPANY OF APPROXIMATELY 28.5 PERCENT

Source text:  ID:nWkr1YGHQm 
Further company coverage:  ONCOZ.ST 

 ((Reuters.Briefs@thomsonreuters.com;))